InsidersTradesSigma
Total declarations
Companies
▲ Purchases (1 ops.)
▼ Sales (4 ops.)
Insider track record
Board DirectorDisclosed buys
1
Disclosed sells
4
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the complete record of transactions filed by DeFord John A, Director. Director active across 4 companies, notably NORDSON CORP. In total, 33 disclosures have been published. Split: 1 buy · 4 sells. Total volume traded: €94k. Activity tracked since 30 April 2021. The latest transaction was filed on 31 July 2026 (Attribution). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to DeFord John A
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations33 total
84 shares@ US$297.78NDSNSEC:0001403373-26-000007:0
46,293 shares0Class A Common StockSEC:0001403373-26-000005:0
91 shares@ US$274.533.6% of flowNDSNSEC:0001403373-26-000002:0
822 shares@ US$231.9529.7% of flowNDSNSEC:0001403373-25-000007:0
89,139 shares@ US$2.1635.7% of flowClass A Common StockSEC:0001823239-25-000080:0
17,500 shares@ US$5.7531.4% of flowClass A Common StockSEC:0001823239-24-000120:0
Canonical exit: 10 Feb 2025 (T+90)
747 shares@ US$249.0337.2% of flowNDSNSEC:0000072331-24-000119:0
20,645 shares@ US$10.7868.6% of flowClass A Common StockSEC:0001823239-24-000073:0
105 shares@ US$212.594.6% of flowNDSNSEC:0000072331-23-000183:0
15,578 sharesClass A Common StockSEC:0001209191-23-048453:0
15,578 sharesClass A Common StockSEC:0001209191-23-048412:0
89 shares@ US$251.614.4% of flowNDSNSEC:0000072331-23-000134:0
31,901 shares0Class A Common StockSEC:0001823239-23-000075:0
104 shares@ US$216.314.4% of flowNDSNSEC:0000072331-23-000091:0
92 shares@ US$243.304.5% of flowNDSNSEC:0000072331-23-000029:0
100 shares@ US$225.004.9% of flowNDSNSEC:0000072331-22-000112:0
97 shares@ US$230.994.8% of flowCommon StockSEC:0001209191-22-043832:0
104 shares@ US$215.690.0001% mcap13.2% of flowCommon StockSEC:0001209191-22-026369:0
96 shares@ US$232.543.5% of flowCommon StockSEC:0001209191-22-005797:0
79 shares@ US$254.213.0% of flowCommon StockSEC:0001209191-21-062406:0
88 shares@ US$226.132.9% of flowCommon StockSEC:0001209191-21-049246:0
94 shares@ US$211.414.2% of flowCommon StockSEC:0001209191-21-029661:0
447 sharesCommon StockSEC:0001225208-16-026588:0
1,650 sharesCommon StockSEC:0001225208-16-026588:1
4,247 sharesCommon StockSEC:0001225208-16-026588:2
25 of 33 declarations
About DeFord John A
DeFord John A is a Director at NORDSON CORP, Maravai Lifesciences Holdings, INC. and Globus Medical INC, and he is also Sr. VP Sci Tech and Clin Afrs at BARD C R INC /NJ/. Across 32 filings in total, the 32 sampled filings run from 2016-02-10 to 2026-05-28, with EUR 94356 in buys and EUR 0 in sells, and the most common transaction nature is Attribution.
